Antwerp University Hospital Reports Findings in Artificial Intelligence (Artificial intelligence scoring of liver biopsies in a phase ii trial of semaglutide in non-alcoholic steatohepatitis)
Antwerp University Hospital Reports Findings in Artificial Intelligence (Artificial intelligence scoring of liver biopsies in a phase ii trial of semaglutide in non-alcoholic steatohepatitis)
扫码查看
点击上方二维码区域，可以放大扫码查看
Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Artificial Intelligence is the subject of a report. According to news reportingout of Antwerp, Belgium, by NewsRx editors, research stated, “Artificial intelligence-powered digitalpathology offers the potential to quantify histologic findings in a reproducible way. This analysis comparesthe evaluation of histological features of non-alcoholic steatohepatitis (NASH) between pathologists and amachine learning (ML) pathology model.”
Key words
Antwerp/Belgium/Europe/Artificial Intelligence/Clinical Research/Clinical Trials and Studies/Drugs and Therapies/Emerging Technologies/GLP-1 Receptor Agonist/Health and Medicine/Liver Diseases and Conditions/Machine Learning/Non-Alcoholic Stea
NETL
NSTL